Gargoyle Investment Advisor’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-75,477
Closed -$3.13M 130
2018
Q4
$3.13M Hold
75,477
2.86% 1
2018
Q3
$3.16M Hold
75,477
2.27% 2
2018
Q2
$2.6M Hold
75,477
1.44% 16
2018
Q1
$2.54M Hold
75,477
1.04% 29
2017
Q4
$2.59M Hold
75,477
1.03% 40
2017
Q3
$2.56M Hold
75,477
0.94% 42
2017
Q2
$2.4M Hold
75,477
0.95% 47
2017
Q1
$2.45M Buy
75,477
+7,805
+12% +$246K 0.95% 42
2016
Q4
$2.08M Hold
67,672
0.81% 58
2016
Q3
$2.17M Hold
67,672
0.82% 62
2016
Q2
$2.26M Hold
67,672
0.84% 58
2016
Q1
$1.9M Hold
67,672
0.64% 79
2015
Q4
$2.07M Hold
67,672
0.84% 47
2015
Q3
$2.02M Hold
67,672
0.83% 50
2015
Q2
$2.15M Hold
67,672
0.82% 48
2015
Q1
$2.23M Buy
+67,672
New +$2.15M 0.84% 53

Other funds holding PFE

Gargoyle Investment Advisor's PFE Position: Q1 2019 in Review

Gargoyle Investment Advisor sold out of Pfizer (PFE) in Q1 2019, closing a stake of 75,477 shares — an estimated $3.13M sold.

Gargoyle Investment Advisor first reported a position in PFE in Q1 2015 and held it in 16 quarters. The position peaked at $3.16M in Q3 2018. 2,391 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • Gargoyle Investment Advisor reported no remaining Pfizer position as of Q1 2019 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 75,477 Pfizer shares in Q1 2019, an estimated $3.13M.
  • Gargoyle Investment Advisor first reported a position in Pfizer in Q1 2015 and held it in 16 quarters.
  • Gargoyle Investment Advisor's Pfizer position peaked at $3.16M in Q3 2018.
  • 2,391 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on Gargoyle Investment Advisor's 13F filing for Q1 2019, filed 14 May 2019.